1. Home
  2. WVE vs BANR Comparison

WVE vs BANR Comparison

Compare WVE & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.19

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Banner Corporation

BANR

Banner Corporation

HOLD

Current Price

$62.78

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
BANR
Founded
2012
1890
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
WVE
BANR
Price
$6.19
$62.78
Analyst Decision
Strong Buy
Hold
Analyst Count
16
4
Target Price
$29.81
$70.00
AVG Volume (30 Days)
3.9M
198.8K
Earning Date
04-28-2026
04-22-2026
Dividend Yield
N/A
3.14%
EPS Growth
N/A
15.57
EPS
N/A
1.60
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$0.73
Revenue Next Year
$85.67
$5.69
P/E Ratio
N/A
$40.60
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$57.05
52 Week High
$21.73
$69.83

Technical Indicators

Market Signals
Indicator
WVE
BANR
Relative Strength Index (RSI) 35.45 41.93
Support Level $6.02 $61.64
Resistance Level $7.65 $63.08
Average True Range (ATR) 0.35 1.24
MACD 0.05 -0.13
Stochastic Oscillator 15.04 10.27

Price Performance

Historical Comparison
WVE
BANR

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: